CIR Renewal for Syncrosome laboratory and animal facilities
Following a decision taken by the Ministry of Higher Education and Research, Syncrosome has been awarded the authorization of « Créd...
22 octobre, 2019 Syncrosome News
Arterial Hypertension
Pulmonary Arterial Hypertension
Myocardial Ischemia
Heart Failure
Blood loss
Parkinson’s Disease (PD)
Stroke
Brain Blood Barrier Passage
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Ulcer
Emesis & Nausea
Gastric Emptying
Intestinal Transit
Type 1 diabetes
Type 2 diabetes
Asthma
COPD
Cough
As an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds.
HIGH CONTENT EFFICACY DATA
PHYSIOLOGICAL BIOMARKERS
FUNCTIONAL EXPLORATION
CELLULAR, MOLECULAR AND INFLAMMATORY BIOMAKERS
IN VIVO EXPERIMENTS
RESOURCES CENTER
15
DISEASE MODELS
130
CUSTOMERS
40
TECHNICAL DATA SHEETS
Download Disease models, Technical sheets, …
Give a tour to Syncrosome Labs !
THEY TRUST US
LATEST NEWS
New preclinical models of Heart Failure presented at the last edition of the GRRC
The participation to the « Spring of Cardiology » offered to Syncrosome the opportunity to present its expertise in the cardiova...
08 octobre, 2019 CardiovascularSyncrosome will attend the 19th Annual Biotech in Europe Forum (Basel, 24th to 26th of October 2019)
The 19th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in...
19 septembre, 2019 Syncrosome NewsSyncrosome will attend the Next BioConvention in Philadelphia, USA
Come and meet Syncrosome at #BIO2019 booth #2109. Syncrosome invites you to visit us at BioConvention, June 3rd to June 7th 2016, in Philadelphia, USA...
28 mai, 2019 Syncrosome News